Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 11/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CASP1 | P29466 | 1/20 | 0.48 |
| ▸ | HBB | P68871 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7308137 | 0.93 | PARP1 (0.60) | PARP1HTR1AKDM4EALDH1A1POLB | |
| SCHEMBL7307836 | 0.91 | PARP1 (0.58) | PARP1HTR1AKDM4EGAA | |
| SCHEMBL7308205 | 0.88 | PARP1 (0.64) | PARP1HTR1AKDM4EALDH1A1MAPT | |
| SCHEMBL7307656 | 0.86 | PARP1 (0.63) | PARP1HTR1AMAPT | |
| SCHEMBL7302855 | 0.86 | PARP1 (0.64) | PARP1 | |
| SCHEMBL7305161 | 0.85 | PARP1 (0.73) | PARP1 | |
| Bromide SCHEMBL7309634 | 0.85 | PARP1 (0.62) | PARP1HTR1AMAPT | |
| Hydrochloric Acid SCHEMBL7301868 | 0.85 | PARP1 (0.62) | PARP1KDM4EGAAMAPT | |
| SCHEMBL7288979 | 0.83 | KDM4E (0.58) | PARP1HTR1AKDM4EALDH1A1POLB | |
| SCHEMBL7303316 | 0.83 | PARP1 (0.64) | PARP1HTR1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5304560-A | Treating CNS disorders; dopamine receptor antagonist | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-04-19 | — | — | US | disclosed |
| EP-0481342-A1 | Quinazoline derivatives and their preparation | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-22 | — | — | EP | disclosed |